27644688|t|Influence of glioblastoma contact with the lateral ventricle on survival: a meta-analysis
27644688|a|The ventricular-subventricular zone (V-SVZ), which lies in the walls of the lateral ventricles (LV), is the largest neurogenic niche within the adult brain. Whether radiographic contact with the LV influences survival in glioblastoma (GBM) patients remains unclear. We assimilated and analyzed published data comparing survival in GBM patients with (LV + GBM) and without (LV - GBM) radiographic LV contact. PubMed, EMBASE, and Cochrane electronic databases were searched. Fifteen studies with survival data on LV + GBM and LV - GBM patients were identified. Their Kaplan-Meier survival curves were digitized and pooled for generation of median overall (OS) and progression free (PFS) survivals and log-rank hazard ratios (HRs). The log-rank and reported multivariate HRs after accounting for the common predictors of GBM survival were analyzed separately by meta-analyses. The calculated median survivals (months) from pooled data were 12.95 and 16.58 (OS), and 4.54 and 6.25 (PFS) for LV + GBMs and LV - GBMs, respectively, with an overall log-rank HRs of 1.335 [1.204-1.513] (OS) and 1.387 [1.225-1.602] (PFS). Meta-analysis of log-rank HRs resulted in summary HRs of 1.58 [1.35-1.85] (OS, 10 studies) and 1.41 [1.22-1.64] (PFS, 5 studies). Meta-analysis of multivariate HRs resulted in summary HRs of 1.35 [1.14-1.58] (OS, 6 studies) and 1.64 [0.88-3.05] (PFS, 3 studies). Patients with GBM contacting the LV have lower survival. This effect may be independent of the common predictors of GBM survival, suggesting a clinical influence of V-SVZ contact on GBM biology.
27644688	0	9	Influence	T077	C4054723
27644688	13	25	glioblastoma	T191	C0017636
27644688	26	38	contact with	T169	C0332158
27644688	43	60	lateral ventricle	T030	C0152279
27644688	64	72	survival	T169	C0220921
27644688	76	89	meta-analysis	T062	C0920317
27644688	94	125	ventricular-subventricular zone	T023	C0504215
27644688	127	132	V-SVZ	T023	C0504215
27644688	166	184	lateral ventricles	T030	C0152279
27644688	186	188	LV	T030	C0152279
27644688	198	205	largest	T081	C0443228
27644688	206	222	neurogenic niche	T030	C4239574
27644688	234	239	adult	T100	C0001675
27644688	240	245	brain	T023	C0006104
27644688	255	267	radiographic	T070	C0444708
27644688	268	280	contact with	T169	C0332158
27644688	285	287	LV	T030	C0152279
27644688	288	298	influences	T077	C4054723
27644688	299	307	survival	T169	C0220921
27644688	311	323	glioblastoma	T191	C0017636
27644688	325	328	GBM	T191	C0017636
27644688	330	338	patients	T101	C0030705
27644688	347	354	unclear	T033	C3845108
27644688	359	370	assimilated	T041	C1999057
27644688	375	383	analyzed	T062	C0936012
27644688	384	393	published	T057	C0034037
27644688	394	398	data	T078	C1511726
27644688	399	408	comparing	T052	C1707455
27644688	409	417	survival	T169	C0220921
27644688	421	424	GBM	T191	C0017636
27644688	425	433	patients	T101	C0030705
27644688	440	442	LV	T030	C0152279
27644688	445	448	GBM	T191	C0017636
27644688	454	461	without	T080	C0332288
27644688	463	465	LV	T030	C0152279
27644688	468	471	GBM	T191	C0017636
27644688	473	485	radiographic	T070	C0444708
27644688	486	488	LV	T030	C0152279
27644688	489	496	contact	T169	C0332158
27644688	498	504	PubMed	T170	C1138432
27644688	506	512	EMBASE	T170	C0993637
27644688	518	547	Cochrane electronic databases	T170	C0242356
27644688	553	561	searched	T052	C1706202
27644688	571	578	studies	T062	C0681814
27644688	584	592	survival	T169	C0220921
27644688	593	597	data	T078	C1511726
27644688	601	603	LV	T030	C0152279
27644688	606	609	GBM	T191	C0017636
27644688	614	616	LV	T030	C0152279
27644688	619	622	GBM	T191	C0017636
27644688	623	631	patients	T101	C0030705
27644688	637	647	identified	T080	C0205396
27644688	655	683	Kaplan-Meier survival curves	T081	C1720944
27644688	689	698	digitized	T080	C1883674
27644688	703	709	pooled	T169	C2349200
27644688	714	724	generation	T052	C3146294
27644688	728	734	median	T081	C0876920
27644688	735	742	overall	T081	C4086681
27644688	744	746	OS	T081	C4086681
27644688	752	784	progression free (PFS) survivals	T081	C0242792
27644688	789	797	log-rank	T170	C0237913
27644688	798	811	hazard ratios	T081	C2985465
27644688	813	816	HRs	T081	C2985465
27644688	823	831	log-rank	T170	C0237913
27644688	836	844	reported	T170	C0684224
27644688	845	857	multivariate	T081	C0026777
27644688	858	861	HRs	T081	C2985465
27644688	868	878	accounting	T057	C0000938
27644688	887	893	common	T081	C0205214
27644688	894	904	predictors	T078	C2698872
27644688	908	911	GBM	T191	C0017636
27644688	912	920	survival	T169	C0220921
27644688	926	934	analyzed	T062	C0936012
27644688	949	962	meta-analyses	T062	C0920317
27644688	968	978	calculated	T169	C0444686
27644688	979	985	median	T081	C0876920
27644688	986	995	survivals	T169	C0220921
27644688	997	1003	months	T079	C0439231
27644688	1010	1016	pooled	T169	C2349200
27644688	1017	1021	data	T078	C1511726
27644688	1044	1046	OS	T081	C4086681
27644688	1068	1071	PFS	T081	C0242792
27644688	1077	1079	LV	T030	C0152279
27644688	1082	1086	GBMs	T191	C0017636
27644688	1091	1093	LV	T030	C0152279
27644688	1096	1100	GBMs	T191	C0017636
27644688	1124	1131	overall	T080	C1561607
27644688	1132	1140	log-rank	T170	C0237913
27644688	1141	1144	HRs	T081	C2985465
27644688	1169	1171	OS	T081	C4086681
27644688	1198	1201	PFS	T081	C0242792
27644688	1204	1217	Meta-analysis	T062	C0920317
27644688	1221	1229	log-rank	T170	C0237913
27644688	1230	1233	HRs	T081	C2985465
27644688	1234	1245	resulted in	T169	C0332294
27644688	1254	1257	HRs	T081	C2985465
27644688	1279	1281	OS	T081	C4086681
27644688	1286	1293	studies	T062	C0681814
27644688	1317	1320	PFS	T081	C0242792
27644688	1324	1331	studies	T062	C0681814
27644688	1334	1347	Meta-analysis	T062	C0920317
27644688	1351	1363	multivariate	T081	C0026777
27644688	1364	1367	HRs	T081	C2985465
27644688	1368	1379	resulted in	T169	C0332294
27644688	1388	1391	HRs	T081	C2985465
27644688	1413	1415	OS	T081	C4086681
27644688	1419	1426	studies	T062	C0681814
27644688	1450	1453	PFS	T081	C0242792
27644688	1457	1464	studies	T062	C0681814
27644688	1467	1475	Patients	T101	C0030705
27644688	1481	1484	GBM	T191	C0017636
27644688	1485	1495	contacting	T169	C0332158
27644688	1500	1502	LV	T030	C0152279
27644688	1508	1513	lower	T052	C2003888
27644688	1514	1522	survival	T169	C0220921
27644688	1529	1535	effect	T080	C1280500
27644688	1543	1557	independent of	T169	C0332291
27644688	1562	1568	common	T081	C0205214
27644688	1569	1579	predictors	T078	C2698872
27644688	1583	1586	GBM	T191	C0017636
27644688	1587	1595	survival	T169	C0220921
27644688	1597	1607	suggesting	T078	C1705535
27644688	1610	1618	clinical	T080	C0205210
27644688	1619	1628	influence	T077	C4054723
27644688	1632	1637	V-SVZ	T023	C0504215
27644688	1638	1645	contact	T169	C0332158
27644688	1649	1652	GBM	T191	C0017636
27644688	1653	1660	biology	T091	C0005532